File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Polymorphisms and mutatons detected in P53 exon 2 and intron 2 in lung carcinomas in Hong Kong

TitlePolymorphisms and mutatons detected in P53 exon 2 and intron 2 in lung carcinomas in Hong Kong
Authors
Issue Date1998
PublisherAmerican College of Chest Physicians. The Journal's web site is located at http://www.chestjournal.org
Citation
The 1998 Clinical World Congress on Diseases of the Chest. Toronto, ON., Canada, 8-12 November 1998. In Chest, 1998, v. 114 n. 4 suppl., p. 249S How to Cite?
AbstractPurpose: Lung cancer is the commonest cause of cancer death in both men and women in Hong Kong, and over 60% of our female patients are non-smokers. Gene mutations are involved in the multistage process of lung tumorigenesis. p53 gene mutations with ethnic differences have been reported. In our previous study of 52 non-small cell lung carcinoma (NSCLC) patients, a polymorphism in p53 intron 2 (A1 and A2 alleles) and a 15% frequency of p53 intron 2 mutations were detected. In the present study, the significance of these polymorphisms and mutations was further studied. Methods: Triple specimens from the lung tumour, normal lung tissue and peripheral blood of 23 NSCLC patients were analysed for polymorphisms and mutations in p53 gene intron 2 and exons 2 and 3 by polymerase chain reaction - single strand conformation polymorphism and direct DNA-sequencing techniques. Results: All cell lines established from peripheral blood lymphocytes shared the same genotypes found in the normal lung tissue, but differed in 4 cases where mutations were detected in the tumours. Detected mutations in the tumour tissues resulted from an A2 to A1 conversion. The A1 allelic frequency appeared to be specifically and significantly increased in the adenocarcinoma tumour tissues as compared to normal tissues in these patients. A new polymorphism localized to p53 exon 2 was detected, appearing with equally high frequency among lung cancer patients and healthy individuals. Conclusions: The p53 intron 2 polymorphic locus is a hot spot for mutations in Hong Kong lung cancer patients and these mutations are probably somatic. Clinical Implications: p53 gene is a commonly affected target gene in our NSCLC patients, and intron 2 mutations may play a role in the malfunction of p53 gene during lung carcinogenesis in Chinese patients in Hong Kong. Peripheral blood DNA may be used to analyse the normal genotype of this locus. The clinical significance of the new p53 polymorphism in exon 2 remains to be elucidated.
Persistent Identifierhttp://hdl.handle.net/10722/148486
ISSN
2023 Impact Factor: 9.5
2023 SCImago Journal Rankings: 2.123

 

DC FieldValueLanguage
dc.contributor.authorLam, WKen_HK
dc.contributor.authorGe, Hen_HK
dc.contributor.authorWong, MPen_HK
dc.contributor.authorLee, Jen_HK
dc.contributor.authorFu, KHen_HK
dc.contributor.authorYew, WWen_HK
dc.contributor.authorLung, MLen_HK
dc.date.accessioned2012-05-29T06:13:14Z-
dc.date.available2012-05-29T06:13:14Z-
dc.date.issued1998en_HK
dc.identifier.citationThe 1998 Clinical World Congress on Diseases of the Chest. Toronto, ON., Canada, 8-12 November 1998. In Chest, 1998, v. 114 n. 4 suppl., p. 249Sen_HK
dc.identifier.issn0012-3692en_HK
dc.identifier.urihttp://hdl.handle.net/10722/148486-
dc.description.abstractPurpose: Lung cancer is the commonest cause of cancer death in both men and women in Hong Kong, and over 60% of our female patients are non-smokers. Gene mutations are involved in the multistage process of lung tumorigenesis. p53 gene mutations with ethnic differences have been reported. In our previous study of 52 non-small cell lung carcinoma (NSCLC) patients, a polymorphism in p53 intron 2 (A1 and A2 alleles) and a 15% frequency of p53 intron 2 mutations were detected. In the present study, the significance of these polymorphisms and mutations was further studied. Methods: Triple specimens from the lung tumour, normal lung tissue and peripheral blood of 23 NSCLC patients were analysed for polymorphisms and mutations in p53 gene intron 2 and exons 2 and 3 by polymerase chain reaction - single strand conformation polymorphism and direct DNA-sequencing techniques. Results: All cell lines established from peripheral blood lymphocytes shared the same genotypes found in the normal lung tissue, but differed in 4 cases where mutations were detected in the tumours. Detected mutations in the tumour tissues resulted from an A2 to A1 conversion. The A1 allelic frequency appeared to be specifically and significantly increased in the adenocarcinoma tumour tissues as compared to normal tissues in these patients. A new polymorphism localized to p53 exon 2 was detected, appearing with equally high frequency among lung cancer patients and healthy individuals. Conclusions: The p53 intron 2 polymorphic locus is a hot spot for mutations in Hong Kong lung cancer patients and these mutations are probably somatic. Clinical Implications: p53 gene is a commonly affected target gene in our NSCLC patients, and intron 2 mutations may play a role in the malfunction of p53 gene during lung carcinogenesis in Chinese patients in Hong Kong. Peripheral blood DNA may be used to analyse the normal genotype of this locus. The clinical significance of the new p53 polymorphism in exon 2 remains to be elucidated.en_HK
dc.languageengen_US
dc.publisherAmerican College of Chest Physicians. The Journal's web site is located at http://www.chestjournal.orgen_HK
dc.relation.ispartofChesten_HK
dc.titlePolymorphisms and mutatons detected in P53 exon 2 and intron 2 in lung carcinomas in Hong Kongen_HK
dc.typeConference_Paperen_HK
dc.identifier.emailWong, MP:mwpik@hkucc.hku.hken_HK
dc.identifier.emailLung, ML:mlilung@hku.hken_HK
dc.identifier.authorityWong, MP=rp00348en_HK
dc.identifier.authorityLung, ML=rp00300en_HK
dc.description.naturelink_to_OA_fulltexten_US
dc.identifier.doi10.1378/chest.114.4_Supplement.249S-
dc.identifier.scopuseid_2-s2.0-33750251852en_HK
dc.identifier.hkuros41318-
dc.identifier.volume114en_HK
dc.identifier.issue4 suppl.en_HK
dc.identifier.spage249Sen_HK
dc.identifier.epage249Sen_HK
dc.publisher.placeUnited Statesen_HK
dc.identifier.scopusauthoridLam, WK=7203021937en_HK
dc.identifier.scopusauthoridGe, H=55137880800en_HK
dc.identifier.scopusauthoridWong, MP=7403907887en_HK
dc.identifier.scopusauthoridLee, J=27169550700en_HK
dc.identifier.scopusauthoridFu, KH=7202283800en_HK
dc.identifier.scopusauthoridYew, WW=16940459600en_HK
dc.identifier.scopusauthoridLung, ML=7006411788en_HK
dc.customcontrol.immutablesml 170104 amended-
dc.identifier.issnl0012-3692-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats